Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,134.7
18.5 (0.59%)

 

  • STI Straits Times Index
    3,134.7
    18.5 (0.59%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.9
    8.7 (0.55%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,664.3
    160.3 (0.61%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,978.7
    -12.3 (-0.41%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,472.9
    265.7 (1.20%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,169.6
    11.4 (0.19%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,082.8
    14.7 (0.71%)
    Index delayed 20 minutes
  • XAO XAO
    6,843.2
    79.9 (1.18%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 990.1M
  • Value: 1,160.8M
  • Rise: 178
  • Fall: 130
  • Unch: 524

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.091+0.012
AIMS APAC Reit1.370-0.110
Spackman0.017+0.003
Thomson Medical0.060+0.002
Golden Agri-Res0.210-0.005
YZJ Shipbldg SGD0.970-
Genting Sing0.920-
Mapletree Log Tr1.700+0.030
Jiutian Chemical0.014+0.001
SingTel3.170-

World Indices

World Indices
Name Last Change
Nasdaq 8,148.7 +100.1
HSI 26,664.3 +160.3
HSCEI 10,532.2 +32.0
Jakarta 6,169.6 +11.4
Nikkei 225 22,472.9 +265.7
SSE Comp 2,978.7 -12.3
Shanghai A 3,120.6 -13.0
Shanghai B 270.1 +0.2
PSE Comp 0.0
KOSPI 2,082.8 +14.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

WUXI BIO WUXI BIO
Quotes 15 Minutes Delayed. Updated at 16 Oct 2019 16:08
Last (HKD): 82.150 Change: +0.800 High: 82.350 Remarks: -
Change (%): +0.98 Low: 80.400
Open 81.800 Yesterday's Close 81.350
Buy Price 82.050 Sell Price 82.150
Buy Volume ('000) 21.5 Sell Volume ('000) 5.5
Cumulative Volume ('000) 1,158.1 Cumulative Value 94,681,095
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.60630 Trailing EPS (HKD) e 0.77555 NAV (HKD) b 7.8858
PE a 135.494 Trailing PE f 105.925 Price / NAV b 10.4175
Dividend (HKD) d - Cash In Hand (HKD) g 2.6535 Issued & Paid-up Shares c 1,231,910,322
Dividend Yield (%) d - Price / Cash In Hand g 30.959 Treasury Shares h 11,749,678
Beta - 75 Daysi 0.667 R-Squared - 75 Days(%)i 15.21 Market Cap (M) 101,201.433
Beta - 500 Daysi 1.238 R-Squared - 500 Days (%)i 18.68 Enterprise Value (M) 98,008.845
Piotroski F Score 5 Exchange Code 2269 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 41.37 6-Month VWAP 76.197 Free Float (%) 53.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 Oct 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 23 Sep 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference WUXI BIO HKEx 101,201.433 135.494 105.925 10.4175 -
Industry Biotechnology HKEx 50,375.120 13.404 14.203 5.6533 2.710
Local Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Local Peer SINO BIOPHARM HKEx 142,093.171 13.261 13.686 4.1745 0.648
Local Peer BEIGENE HKEx 58,681.498 - - 4.8339 -
Local Peer 3SBIO HKEx 34,983.414 23.126 28.148 3.4480 -
Local Peer GENSCRIPT BIO HKEx 29,063.268 174.790 - 8.1959 -
Local Peer FRONTAGE HKEx 10,921.562 123.974 123.965 5.6525 -
Local Peer VIVA BIOTECH HKEx 7,956.349 74.184 74.183 4.1307 -
Local Peer HAOHAI BIOTEC HKEx 6,449.826 13.136 14.558 1.5186 1.451
Local Peer ASCLETIS-B HKEx 3,350.863 - - 0.8694 -
Local Peer CKLIFE SCIENCES HKEx 3,411.930 12.975 12.957 0.8172 2.817
Local Peer ESSEX BIO-TECH HKEx 3,311.579 14.330 12.652 3.1492 1.101
Local Peer LEE'S PHARM HKEx 2,641.698 6.316 7.986 1.1656 2.644
Other Local Peers BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), REGENT PACIFIC (HKEx), BIOSINO BIO-TEC (HKEx), EXTRAWELL PHAR (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 122,734.807 14.622 15.423 11.3706 2.709
Global Peer GILEAD SCIENCES INC NASDAQ 82,699.185 15.160 13.887 3.6567 3.534
Global Peer CSL ASX 114,826.327 42.799 42.799 15.3447 1.049
Global Peer CELGENE CORP NASDAQ 71,547.404 17.684 13.574 7.1184 -
Global Peer ILLUMINA INC NASDAQ 45,888.990 55.556 48.922 10.5930 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 45,274.145 21.596 20.440 8.9299 -
Global Peer BIOGEN INC NASDAQ 41,696.089 9.411 7.876 3.2191 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 33,388.101 13.659 16.135 3.4223 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,501.232 302.849 17.622 2.3123 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,442.201 74.184 21.868 4.9383 0.808
Other Global Peers INCYTE CORPORATION (NASDAQ), SEATTLE GENETICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NATERA INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), 10X GENOMICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), INSMED INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), VERACYTE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), POLYNOVO LIMITED (ASX), ESPERION THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ALECTOR INC (NASDAQ), VIELA BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANAPTYSBIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), EPIZYME INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), OMEROS CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AVITA MEDICAL LTD (ASX), STOKE THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KODIAK SCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD (ASX), ROCKET PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CORTEXYME INC (NASDAQ), NEXTCURE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), MACROGENICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), RETROPHIN INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), VIKING THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), AVROBIO INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), IMMUNOGEN INC (NASDAQ), AGENUS INC (NASDAQ), XBIOTECH INC (NASDAQ), PERSONALIS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NYSE), LEXICON PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), NEXT SCIENCE LTD (ASX), CYTOMX THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MEDICINOVA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), DERMIRA INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ARDELYX INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), TELIX PHARMACEUTIC (ASX), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), COMPUGEN (NASDAQ), RESTORBIO INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MANNKIND CORPORATION (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SERES THERAPEUTICS (NASDAQ), DPHARMA (Bursa), GALECTIN THERAPEUTICS INC (NASDAQ), PFENEX INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ATHERSYS INC (NASDAQ), KAMADA (NASDAQ), CHIASMA INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), ELOXX PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ENZO BIOCHEM INC (NYSE), PIERIS PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), RESAPP HEALTH LIMITED (ASX), ALDEYRA THERAPEUTICS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), CALITHERA BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), AXCELLA HEALTH INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), IMV INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), NANTKWEST INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SESEN BIO INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), NOVAVAX INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), PARATEK PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), PHYLOGICA LIMITED (ASX), VBI VACCINES INC CDA (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TREVENA INC (NASDAQ), CHIMERIX INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), VERASTEM INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ARAVIVE INC (NASDAQ), IMMUTEP LTD (ASX), CEL-SCI CORP (NYSE American), VTV THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), OTONOMY INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), INFINITY PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), EQUILLIUM INC (NASDAQ), PORT (SET), SELECTA BIOSCIENCES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IMUGENE LIMITED (ASX), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), ORTHOCELL LIMITED (ASX), UNUM THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), VERMILLION INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIONOMICS LTD (ASX), EVOGENE LTD (NASDAQ), IVERIC BIO INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), OUTLOOK THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SAVARA INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), IBIO INC (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), MEMPHASYS LTD (ASX), BIO-PATH HOLDINGS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIOTRON (ASX), FIBROCELL SCIENCE INC (NASDAQ), RHINOMED LIMITED (ASX), ALIMERA SCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), CONTRAFECT CORP (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), DIAMEDICA THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ORAGENICS INC (NYSE American), SIERRA ONCOLOGY INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), SOLIGENIX INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIOCEPT INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ISORAY INC (NYSE American), AEVI GENOMIC MEDIC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMMURON LIMITED (ASX), OCUGEN INC (NASDAQ), PATRYS LIMITED (ASX), PRECIPIO INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VAXART INC (NASDAQ), ADALTA LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), PULMATRIX INCORPORATED (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), REGENEUS LTD (ASX), Suntar Eco-City^ (SGX), GENETIC TECHNOLOGIES (ASX), TOCAGEN INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), HEAT BIOLOGICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ATYR PHARMA INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CELLMID LIMITED (ASX), CONATUS PHARMACEUTICALS INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), CAPRICOR THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), MEDIBIO LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), BIOXYNE LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), MGRC (Bursa), ARCA BIOPHARMA INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ONCONOVA THERAPEUTICS INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), TROVAGENE INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MEGASUN (Bursa), TBG DIAGNOSTICS LTD (ASX), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), QT Vascular (SGX), CCP TECHNOLOGIES LTD (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), NOVITA HEALTHCARE LTD (ASX), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), SPHERIX INC (NASDAQ), NANOLLOSE LTD (ASX), NEURALSTEM INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), BPH ENERGY LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.500
+1.86 %
10 Days -+2.150
+2.69 %
20 Days -+2.700
+3.40 %
Medium Term Return 3 Months -+6.800
+9.02 %
6 Months --1.700
-2.03 %
1 Year -+18.200
+28.46 %
Long Term Return 2 Years -+42.450
+106.93 %
Annualised Return Annualised --
+43.85 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 44.500 - 86.950 Change From 1 Year Low +37.650 % Change From 1 Year Low (%) +84.61
Change From 1 Year High -4.800 % Change From 1 Year High (%) -5.52
2 Years Range 39.300 - 98.500 Change From 2 Years Low +42.850 % Change From 2 Years Low (%) +109.03
Change From 2 Years High -16.350 % Change From 2 Years High (%) -16.60
5 Years Range 25.000 - 98.500 Change From 5 Years Low +57.150 % Change From 5 Years Low (%) +228.60
Change From 5 Years High -16.350 % Change From 5 Years High (%) -16.60
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Wuxi Biologics (Cayman), Inc. is an investment holding company, which engages in the discovery, development and manufacture of biologics services. Its services include testing; clinical drug substance cGMP manufacture; commercial drug substance cGMP manufacture; drug product cGMP fill and finish; antibody drug conjugates; regulatory affairs; and technologies and platforms. The company was founded on May 24, 2010 and is headquartered in Wuxi, China.

Historical Price Data

Date Open High Low Close Volume VWAP
16 Oct 2019 81.800 82.200 80.400 82.000 451,100 81.2305
15 Oct 2019 82.000 83.000 80.450 81.350 2,980,365 81.7414
14 Oct 2019 82.500 84.300 81.550 81.750 2,355,344 82.6192
11 Oct 2019 81.400 83.400 81.350 82.500 6,725,625 82.8395
10 Oct 2019 79.850 81.700 78.300 81.200 2,410,146 80.2132
09 Oct 2019 79.600 80.600 78.700 79.350 1,604,024 79.3550
08 Oct 2019 81.000 82.000 80.100 80.650 2,560,992 81.3952
04 Oct 2019 79.150 82.000 78.750 79.950 2,569,796 80.3137
03 Oct 2019 78.000 79.650 77.300 78.650 1,283,704 78.5146
02 Oct 2019 78.500 79.900 78.400 78.800 1,326,872 78.8667
30 Sep 2019 78.800 80.000 77.250 80.000 2,527,385 79.6860
27 Sep 2019 79.200 79.950 78.650 78.800 1,218,564 79.0542
26 Sep 2019 79.750 80.200 78.350 80.000 2,693,400 79.8597
25 Sep 2019 79.450 80.700 78.200 78.750 2,195,040 79.1755
24 Sep 2019 79.550 80.500 78.350 80.000 2,136,530 79.2918
23 Sep 2019 80.500 81.450 79.050 79.900 2,483,927 80.2826
20 Sep 2019 78.750 80.550 77.800 79.900 3,424,102 79.8028
19 Sep 2019 78.450 78.800 77.000 78.250 2,110,842 78.0208
18 Sep 2019 79.900 81.400 77.900 78.100 2,215,037 79.1759
17 Sep 2019 79.650 79.900 78.200 79.450 1,170,672 79.0234
16 Sep 2019 80.700 80.700 78.800 79.350 1,700,412 79.4532
13 Sep 2019 80.200 80.300 79.400 80.000 1,647,191 79.9441
Summary
Current 2 Weeks
(02 Oct 2019 to 16 Oct 2019)
78.500 84.300 77.300 82.000 24,267,968 -
Previous 2 Weeks
(17 Sep 2019 to 30 Sep 2019)
79.650 84.300 77.300 80.000 22,175,499 -
4 Weeks from
(20 Aug 2019 to 16 Sep 2019)
82.000 84.300 77.300 79.350 79,714,969 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.